Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Merck
McKinsey
Julphar
Farmers Insurance
AstraZeneca
Chubb
McKesson
Chinese Patent Office

Generated: April 23, 2018

DrugPatentWatch Database Preview

GANTANOL-DS Drug Profile

« Back to Dashboard

When do Gantanol-ds patents expire, and when can generic versions of Gantanol-ds launch?

Gantanol-ds is a drug marketed by Roche and is included in one NDA.

The generic ingredient in GANTANOL-DS is sulfamethoxazole. There are twenty-seven drug master file entries for this compound. Additional details are available on the sulfamethoxazole profile page.
Drug patent expirations by year for GANTANOL-DS
Medical Subject Heading (MeSH) Categories for GANTANOL-DS
Synonyms for GANTANOL-DS
[(4-aminophenyl)sulfonyl](5-methylisoxazol-3-yl)amine
08D
129378-89-8
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(para-Aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-[N-(5-Methylisoxazol-3-yl)sulphamoyl]aniline
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide; N1-(5-Methylisoxazol-3-yl)sulfanilamide
4-AMINO-N-(5-METHYL-3-ISOXAZOYL)BENZENESULFONAMIDE
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzene sulfonamide
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
4-Amino-N-[5-methyl-3- isoxazolyl]benzenesulfonamide
4-AMINO-N-[5-METHYL-3-ISOXAZOLYL]BENZENESULFONAMID
4-Amino-N-[5-methyl-3-isoxazolyl]benzenesulfonamide
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
723-46-6
A047
AB00052099
AB00052099_17
AB00052099_18
AB00052099-14
AB00052099-16
AB1009297
AC-11118
AC1L1K42
AC1Q2J5R
AK-36221
AKOS000200952
ALBB-002089
AN-22110
ANW-43073
Apo-Sulfamethoxazole
ARONIS018156
Azo gantanol
Azo-gantanol
Bactrimel
BAS 00836086
BB 0242379
BB_SC-1251
BBL004554
BCP0726000283
BDBM50029770
Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-
BIDD:GT0731
BPBio1_000081
BRD-K28494619-001-05-0
BRN 0226453
BS-3542
BSPBio_000073
BSPBio_002028
C07315
C10H11N3O3S
CAS-723-46-6
CCG-40166
CCRIS 567
CHEBI:9332
CHEMBL443
Co-trimoxazole (Salt/Mix)
component of Azo Gantanol (Salt/Mix)
component of Bactrim (Salt/Mix)
CPD000058223
CS-2363
CTK5D5959
D00447
D0AE2X
D0R9OH
DB01015
DivK1c_000649
DRG-0031
DSSTox_CID_6064
DSSTox_GSID_26064
DSSTox_RID_78001
DTXSID8026064
EBD3403
EINECS 211-963-3
Epitope ID:114999
Eusaprim (Salt/Mix)
FT-0602616
Gamazole
Gantanol
Gantanol DS
H463
HE003759
HE305520
HMS1568D15
HMS1921A21
HMS2092K03
HMS2095D15
HMS2233L13
HMS3259E06
HMS3372M22
HMS3655O22
HMS502A11
HMS561O18
HSDB 3186
HTS001394
HY-B0322
I01-0154
IDI1_000649
InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
J10090
JE42381TNV
JLKIGFTWXXRPMT-UHFFFAOYSA-
JLKIGFTWXXRPMT-UHFFFAOYSA-N
KB-97587
KBio1_000649
KBio2_001474
KBio2_004042
KBio2_006610
KBio3_001528
KBioGR_000749
KBioSS_001474
KM1475
KS-000000QU
KS-00004AEJ
KSC635S5T
LS-1620
Maybridge1_007190
MCULE-1450176600
Metoxal
MFCD00010546
MLS000069732
MLS001055354
MLS001074165
MLS006011871
MolPort-000-145-787
MS 53
N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide
N'-(5-Methyl-3-isoxazole)sulfanilamide
N'-(5-Methyl-3-isoxazolyl)-Sulfanilamide
N'-(5-Methyl-3-isoxazolyl)sulfanilamide
N'-(5-Methylisoxazol-3-yl)sulphanilamide
N(1)-(5-Methyl-3-isoxazolyl)sulphanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide
N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-methyl-3-isoxazolyl)-Sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
N1-(5-methylisoxazol-3-yl)-4-aminobenzene-1-sulfonamide
N1-(5-Methylisoxazol-3-yl)sulfanilamide
NC00537
NCGC00016533-01
NCGC00016533-02
NCGC00016533-03
NCGC00016533-04
NCGC00016533-05
NCGC00016533-06
NCGC00016533-07
NCGC00016533-08
NCGC00016533-09
NCGC00016533-10
NCGC00016533-11
NCGC00016533-12
NCGC00016533-14
NCGC00021995-03
NCGC00021995-04
NCGC00021995-05
NCGC00186654-01
NCGC00257907-01
Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide
NINDS_000649
NSC 147832
NSC-147832
NSC-757328
NSC147832
NSC757328
Opera_ID_882
Oprea1_114486
Oprea1_285680
Pharmakon1600-01500550
Prestwick_453
Prestwick0_000177
Prestwick1_000177
Prestwick2_000177
Prestwick3_000177
Q-201762
Radonil
Ro 4-2130
Ro 6-2580/11
Ro-4-2130
Ro-42130
RTR-023663
S0361
s1915
SAM002554930
SBB057675
SBB071655
SBI-0051524.P003
SC-15160
SCHEMBL3656
Septran
Septran (Salt/Mix)
Septrin (Salt/Mix)
Septrin (TN)
Simsinomin
Sinomin
SMR000058223
SMX
Solfametossazolo
Solfametossazolo [DCIT]
SPBio_000896
SPBio_001994
Spectrum_000994
SPECTRUM1500550
Spectrum2_000788
Spectrum3_000584
Spectrum4_000345
Spectrum5_000982
SR-01000000217
SR-01000000217-2
ST024740
ST2418109
ST51006798
STK007988
Sulfamethalazole
Sulfamethoxazol
sulfamethoxazole
SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE)
SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE); TMP/SMX (MIXTURE))
Sulfamethoxazole (JP15/USP/INN)
Sulfamethoxazole (JP17/USP/INN)
Sulfamethoxazole [USAN:INN:JAN]
Sulfamethoxazole [USAN:USP:INN:BAN:JAN]
Sulfamethoxazole sodium
Sulfamethoxazole, analytical standard
Sulfamethoxazole, certified reference material, TraceCERT(R)
Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard
Sulfamethoxazole, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard
Sulfamethoxazole, VETRANAL(TM), analytical standard
Sulfamethoxazole(USAN)
Sulfamethoxazolum
Sulfamethoxazolum [INN-Latin]
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfametoxazol [INN-Spanish]
Sulfanilamide, N'-(5-methyl-3-isoxazolyl)-
Sulfanilamide, N(1)-(5-methyl-3-isoxazolyl)-
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)-
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI)
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)-(8CI)
Sulfisomezole
Sulpha-methoxizole
Sulphameth oxazole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulphamethylisoxazole
Sulphisomezole
TL8005058
Tox21_110480
Tox21_110480_1
Tox21_200353
TRA0076970
Trib
UNII-JE42381TNV
Urobak
WLN: T5NOJ C1 EMSWR DZ
Z57198677
ZINC89763

US Patents and Regulatory Information for GANTANOL-DS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche GANTANOL-DS sulfamethoxazole TABLET;ORAL 012715-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
US Department of Justice
Deloitte
Fish and Richardson
Mallinckrodt
Teva
McKinsey
QuintilesIMS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.